PI3Kγ是一个控制免疫抑制的分子开关
Megan M Kaneda1, Karen S Messer1,2, Natacha Ralainirina1
1Moores Cancer Center, University of California, San Diego, La Jolla, California 92093, USA.
Nature
|November 8, 2016
概括
在炎症和癌症中,巨酸3-激酶 (PI3Kγ) 作为免疫刺激和抑制之间的切换. 抑制PI3Kγ可促进抗瘤免疫力,并增强检查点抑制剂治疗的疗效.
科学领域:
- 免疫学
- 分子生物学
- 癌症学
背景情况:
- 巨细胞在炎症和癌症中发挥双重作用,促进免疫刺激或抑制.
- 巨分化对于调节各种疾病的免疫反应至关重要.
研究的目的:
- 在控制免疫反应方面研究巨酸三基酶 (PI3Kγ) 的作用.
- 确定PI3Kγ信号是否调节免疫刺激和免疫抑制巨细胞表型之间的切换.
- 评估PI3Kγ作为癌症治疗点.
主要方法:
- 使用基因操纵在小鼠模型中选择性地禁用巨细胞PI3Kγ.
- 分析了下游信号通路,包括Akt,mTOR,NFκB和C/EBPβ.
- 评估PI3Kγ调节和检查点抑制剂治疗的T细胞激活,细胞毒性和瘤回归.
主要成果:
- 大细胞PI3Kγ信号通过抑制NFκB和激活C/EBPβ促进免疫抑制.
- 在巨细胞中选择性PI3Kγ无活化会增强NFκB的活化,并促进免疫刺激的表型.
- 在小鼠癌症模型中,PI3Kγ抑制与检查点抑制剂协同作用,诱导瘤回归并改善存活率.
- 通过PI3Kγ调节的基因表达可以预测患者的存活率.
结论:
- 巨PI3Kγ是炎症和癌症免疫反应的关键调节者.
- 向PI3Kγ可以将巨细胞重新编程到免疫刺激状态,增强抗瘤免疫力.
- 抑制PI3Kγ是一种有前途的治疗策略,特别是在与检查点抑制剂相结合时,用于癌症治疗.
更多相关视频
07:21Molecular and Immunologic Techniques in a Genetically Engineered Mouse Model of Gastrointestinal Stromal Tumor
Published on: May 2, 2022
2.7K
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
1.0K
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
6.1K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
6.1K
The JAK-STAT Signaling Pathway
13.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
13.6K
Abnormal Proliferation
5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Interactions Between Signaling Pathways
7.7K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.7K
TGF - β Signaling Pathway
10.8K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.8K
mTOR Signaling and Cancer Progression
5.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
5.0K
